CS300 IABP. Software Version CS300 IABP C.01.

Recall Insight

This FDA Devices action (record #Z-1487-2026) was formally reported on March 11, 2026, with the manufacturer initiating the action on January 23, 2026. It is classified under Moderate severity (Class II), with a current status of Ongoing. Datascope Corp. is listed as the recalling firm, operating out of Mahwah, NJ. Federal records indicate 10,897 units units are affected.

The documented reason for this recall is: The firm has identified that the battery runtime and cycle specifications contained in the devices Instructions for Use (IFU) need to be updated. Distribution data in the federal record shows the product reached: Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Bolivia, Bosnia And Herzegovina, Bra…. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. Because this recall is recent, remedy windows and replacement inventory are most likely still actively available from the firm or retailer. Always cross-check the recall number against the official agency page before relying on any summary.